Table 1 (Doxazosin Fig1)
This is a table summarizing the effectiveness data of placebo-controlled trials. The table shows maximum flow rate and symptom score data for each study, including the number of patients, baseline score, and change in score. Study 1 showcased maximum dose of Vatinum Fo, Study 2 showed fixed-dose and titration for 14 weeks, and Study 3 showed titration for 12 weeks. Different dosages of doxazosin were also compared to placebo. The questionnaire used for evaluating symptoms varied among the studies and ranged from 0 to 39; however, specific scores were not provided.*